Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis (original) (raw)

Abstract

One of the characteristic features of microglia is their rapid activation in response to injury, inflammation, neurodegeneration, infection, and brain tumors. This review focuses on the role of the microglia in multiple sclerosis (MS), a chronic inflammatory demyelinating disease of the central nervous system (CNS), and in the animal model of MS, experimental allergic encephalomyelitis (EAE). Microglial activation in MS and EAE is thought to contribute directly to CNS damage through several mechanisms, including production of proinflammatory cytokines, matrix metalloproteinases, and free radicals. In addition, activated microglia serve as the major antigen-presenting cell in the CNS, likely contributing to aberrant immune reactivity at this site. A mechanistic understanding of the way in which microglia are activated and ultimately inhibited is crucial for the formulation of therapeutic modalities to treat MS and other CNS autoimmune diseases.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35294–0005, USA, , , , , , US
    Etty N. Benveniste

Authors

  1. Etty N. Benveniste
    You can also search for this author inPubMed Google Scholar

Additional information

Received: 6 June 1996 / Accepted: 4 October 1996

Rights and permissions

About this article

Cite this article

Benveniste, E. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis.J Mol Med 75, 165–173 (1997). https://doi.org/10.1007/s001090050101

Download citation